Novak Djokovic has been sailing through uncharted territory since the beginning of 2024! The 24-time Major winner opened up after his Indian Wells defeat, admitting he has been struggling to find ...

There was a time, not so long ago, when Novak Djokovic lost so rarely that ... Elsewhere at Indian Wells, the USA’s Taylor Fritz defeated Matteo Gigante 6-3, 7-5 in his opening match of the ...

After a poor 2024 outing at the desert where he lost in the second round, Novak Djokovic is set to compete despite injury concerns. Seeded sixth for the competition, the Serbian would be hoping to ...

Free Expression: Judging by Democrats' reaction at USAID, the Treasury and the Department of Education, Elon Musk’s Department of Government Efficiency looks less DOGE and more DOGA, a ...

U.S. inflation data for February will be the highlight among economic data as investors continue to follow the back-and-forth of U.S. President Trump’s announcements on tariffs. A rate decision ...

The Penguins picked up Schenn and forward Tommy Novak from the Nashville Predators for winger Michael Bunting and a 2026 fourth-round pick Wednesday. Schenn is under contract for one more season ...

I’m really happy I’m able to train with him,” said Novak. Adding another layer is that Hysong’s Olympic coach was Greg Hull, who was the senior coach for USA Track and Field Olympic ...

Below we break down his form in recent events to help you make your best bets on Novak before he tees off ... For a full list of sports betting odds, access USA TODAY Sports Betting Scores Odds ...

You can also opt for USA + Canada plans. Ubigi is a fully independent mobile virtual network operator (MVNO), operating on its own core network infrastructure, which means users will have higher ...

The deal sees Lilly pay out $9 million upfront plus another $1 million after 15 months to the San Diego biotech, according to Securities and Exchange Commission (SEC) documents filed Feb. 25.

In September, Akeso, a little-known Chinese biotech company founded nearly a decade ago shook up the biotech sector with its new lung cancer drug. Ivonescimab, the new drug, was found in a trial ...